Literature DB >> 20106987

Recessive COL6A2 C-globular missense mutations in Ullrich congenital muscular dystrophy: role of the C2a splice variant.

Rui-Zhu Zhang1, Yaqun Zou, Te-Cheng Pan, Dessislava Markova, Andrzej Fertala, Ying Hu, Stefano Squarzoni, Umbertina Conti Reed, Suely K N Marie, Carsten G Bönnemann, Mon-Li Chu.   

Abstract

Ullrich congenital muscular dystrophy (UCMD) is a disabling and life-threatening disorder resulting from either recessive or dominant mutations in genes encoding collagen VI. Although the majority of the recessive UCMD cases have frameshift or nonsense mutations in COL6A1, COL6A2, or COL6A3, recessive structural mutations in the COL6A2 C-globular region are emerging also. However, the underlying molecular mechanisms have remained elusive. Here we identified a homozygous COL6A2 E624K mutation (C1 subdomain) and a homozygous COL6A2 R876S mutation (C2 subdomain) in two UCMD patients. The consequences of the mutations were investigated using fibroblasts from patients and cells stably transfected with the mutant constructs. In contrast to expectations based on the clinical severity of these two patients, secretion and assembly of collagen VI were moderately affected by the E624K mutation but severely impaired by the R876S substitution. The E624K substitution altered the electrostatic potential of the region surrounding the metal ion-dependent adhesion site, resulting in a collagen VI network containing thick fibrils and spots with densely packed microfibrils. The R876S mutation prevented the chain from assembling into triple-helical collagen VI molecules. The minute amount of collagen VI secreted by the R876S fibroblasts was solely composed of a faster migrating chain corresponding to the C2a splice variant with an alternative C2 subdomain. In transfected cells, the C2a splice variant was able to assemble into short microfibrils. Together, the results suggest that the C2a splice variant may functionally compensate for the loss of the normal COL6A2 chain when mutations occur in the C2 subdomain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106987      PMCID: PMC2843164          DOI: 10.1074/jbc.M109.093666

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Structural basis of type VI collagen dimer formation.

Authors:  Stephen Ball; Jordi Bella; Cay Kielty; Adrian Shuttleworth
Journal:  J Biol Chem       Date:  2002-12-07       Impact factor: 5.157

Review 2.  Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.

Authors:  Charles A Whittaker; Richard O Hynes
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

3.  Structure and allosteric regulation of the alpha X beta 2 integrin I domain.

Authors:  Thomas Vorup-Jensen; Christian Ostermeier; Motomu Shimaoka; Ulrich Hommel; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-28       Impact factor: 11.205

Review 4.  Integrin activation and structural rearrangement.

Authors:  Junichi Takagi; Timothy A Springer
Journal:  Immunol Rev       Date:  2002-08       Impact factor: 12.988

5.  A Bethlem myopathy Gly to Glu mutation in the von Willebrand factor A domain N2 of the collagen alpha3(VI) chain interferes with protein folding.

Authors:  T Sasaki; E Hohenester; R Z Zhang; S Gotta; M C Speer; R Tandan; R Timpl; M L Chu
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

6.  Mutations in COL6A3 cause severe and mild phenotypes of Ullrich congenital muscular dystrophy.

Authors:  Ercan Demir; Patrizia Sabatelli; Valérie Allamand; Ana Ferreiro; Behzad Moghadaszadeh; Mohamed Makrelouf; Haluk Topaloglu; Bernard Echenne; Luciano Merlini; Pascale Guicheney
Journal:  Am J Hum Genet       Date:  2002-04-24       Impact factor: 11.025

7.  Frameshift mutation in the collagen VI gene causes Ullrich's disease.

Authors:  I Higuchi; T Shiraishi; T Hashiguchi; M Suehara; T Niiyama; M Nakagawa; K Arimura; I Maruyama; M Osame
Journal:  Ann Neurol       Date:  2001-08       Impact factor: 10.422

8.  Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype.

Authors:  P C Scacheri; E M Gillanders; S H Subramony; V Vedanarayanan; C A Crowe; N Thakore; M Bingler; E P Hoffman
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

9.  Effects on collagen VI mRNA stability and microfibrillar assembly of three COL6A2 mutations in two families with Ullrich congenital muscular dystrophy.

Authors:  Rui-Zhu Zhang; Patrizia Sabatelli; Te-Cheng Pan; Stefano Squarzoni; Elisabetta Mattioli; Enrico Bertini; Guglielmina Pepe; Mon-Li Chu
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

10.  Autosomal recessive myosclerosis myopathy is a collagen VI disorder.

Authors:  L Merlini; E Martoni; P Grumati; P Sabatelli; S Squarzoni; A Urciuolo; A Ferlini; F Gualandi; P Bonaldo
Journal:  Neurology       Date:  2008-10-14       Impact factor: 9.910

View more
  11 in total

1.  Collagen VI microfibril formation is abolished by an {alpha}2(VI) von Willebrand factor type A domain mutation in a patient with Ullrich congenital muscular dystrophy.

Authors:  Leona D Tooley; Laura K Zamurs; Nicola Beecher; Naomi L Baker; Rachel A Peat; Naomi E Adams; John F Bateman; Kathryn N North; Clair Baldock; Shireen R Lamandé
Journal:  J Biol Chem       Date:  2010-08-21       Impact factor: 5.157

2.  Structure of a collagen VI α3 chain VWA domain array: adaptability and functional implications of myopathy causing mutations.

Authors:  Herimela Solomon-Degefa; Jan M Gebauer; Cy M Jeffries; Carolin D Freiburg; Patrick Meckelburg; Louise E Bird; Ulrich Baumann; Dmitri I Svergun; Raymond J Owens; Jörn M Werner; Elmar Behrmann; Mats Paulsson; Raimund Wagener
Journal:  J Biol Chem       Date:  2020-07-21       Impact factor: 5.157

3.  Detecting collagen VI in Bethlem myopathy.

Authors:  Patrizia Sabatelli; Francesca Gualandi; Paolo Bonaldo; Luciano Merlini
Journal:  J Biol Chem       Date:  2015-03-20       Impact factor: 5.157

4.  Collagen: quantification, biomechanics, and role of minor subtypes in cartilage.

Authors:  Benjamin J Bielajew; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Nat Rev Mater       Date:  2020-07-20       Impact factor: 66.308

5.  Aberrant mitochondria in a Bethlem myopathy patient with a homozygous amino acid substitution that destabilizes the collagen VI α2(VI) chain.

Authors:  Laura K Zamurs; Miguel A Idoate; Eric Hanssen; Asier Gomez-Ibañez; Pau Pastor; Shireen R Lamandé
Journal:  J Biol Chem       Date:  2014-12-22       Impact factor: 5.157

Review 6.  The collagen VI-related myopathies: muscle meets its matrix.

Authors:  Carsten G Bönnemann
Journal:  Nat Rev Neurol       Date:  2011-06-21       Impact factor: 42.937

7.  ColVI myopathies: where do we stand, where do we go?

Authors:  Valérie Allamand; Laura Briñas; Pascale Richard; Tanya Stojkovic; Susana Quijano-Roy; Gisèle Bonne
Journal:  Skelet Muscle       Date:  2011-09-23       Impact factor: 4.912

8.  Causative variant profile of collagen VI-related dystrophy in Japan.

Authors:  Michio Inoue; Yoshihiko Saito; Takahiro Yonekawa; Megumu Ogawa; Aritoshi Iida; Ichizo Nishino; Satoru Noguchi
Journal:  Orphanet J Rare Dis       Date:  2021-06-24       Impact factor: 4.123

9.  Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy.

Authors:  Vitali Alexeev; Machiko Arita; Adele Donahue; Paolo Bonaldo; Mon-Li Chu; Olga Igoucheva
Journal:  Stem Cell Res Ther       Date:  2014-02-12       Impact factor: 6.832

10.  Diagnostic approach to the congenital muscular dystrophies.

Authors:  Carsten G Bönnemann; Ching H Wang; Susana Quijano-Roy; Nicolas Deconinck; Enrico Bertini; Ana Ferreiro; Francesco Muntoni; Caroline Sewry; Christophe Béroud; Katherine D Mathews; Steven A Moore; Jonathan Bellini; Anne Rutkowski; Kathryn N North
Journal:  Neuromuscul Disord       Date:  2014-01-09       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.